Wordt geladen...
Improving gemcitabine-mediated radiosensitization using molecularly targeted therapy: A review
In the last three decades gemcitabine has progressed from the status of a laboratory cytotoxic drug to a standard clinical chemotherapeutic agent and a potent radiation sensitizer. In an effort to improve the efficacy of gemcitabine, additional chemotherapeutic agents have been combined with gemcita...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2008
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2697824/ https://ncbi.nlm.nih.gov/pubmed/18980967 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-1032 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|